Search

Search Constraints

You searched for: Author/Creator Minisini, Alessandro Marco

Search Results

1. Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. (February 2017)

2. Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy. (12th March 2018)

3. Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey. (August 2018)

4. Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting. (21st April 2017)

5. Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting. (June 2017)

6. Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID‐19 Pandemic. (19th February 2021)

7. First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study. (June 2021)

9. Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer. (February 2018)

10. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. Issue 2 (15th October 2020)